Antigiardial activity of isoflavones from Dalbergia frutescens bark

被引:79
作者
Khan, IA
Avery, MA
Burandt, CL
Goins, DK
Mikell, JR
Nash, TE
Azadegan, A
Walker, LA [1 ]
机构
[1] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, Natl Ctr Nat Prod Res, University, MS 38677 USA
[2] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
[3] Univ Mississippi, Sch Pharm, Dept Med Chem & Pharmacol, University, MS 38677 USA
[4] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[5] NIH, Vet Resources Program, Off Director, Bethesda, MD 20892 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2000年 / 63卷 / 10期
关键词
D O I
10.1021/np000010d
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Several isoflavones [formononetin (1), castanin (5), odoratin (6), glycitein (7), pseudebaptogenin (8), fujikinetin (9), and cuneatin (10)] were isolated from Dalbergia frutescens, and their antiprotozoal activities were determined against Giardia intestinalis. Among these compounds, formononetin (1) was the most potent antigiardial agent, with an IC50 value of 30 ng/mL (approximately 0.1 muM), as compared to the value for metronidazole, the current drug of choice, of 100 ng/mL (approximately 0.6 muM). Three isoflavones closely related to formononetin [daidzein (2), biochanin A (3) and genistein (4)] were also evaluated, but they were at least 100 times less active than 1. Formononetin (1) may thus be an interesting lead for development of new antigiardial agents eras a probe for a new mechanistic target.
引用
收藏
页码:1414 / 1416
页数:3
相关论文
共 19 条
[1]   COMPARISONS OF 2-INVITRO CYTO-TOXICITY ASSAYS - THE NEUTRAL RED (NR) AND TETRAZOLIUM MTT TESTS [J].
BORENFREUND, E ;
BABICH, H ;
MARTINALGUACIL, N .
TOXICOLOGY IN VITRO, 1988, 2 (01) :1-6
[2]   GIARDIA-LAMBLIA INFECTIONS IN ADULT MICE [J].
BYRD, LG ;
CONRAD, JT ;
NASH, TE .
INFECTION AND IMMUNITY, 1994, 62 (08) :3583-3585
[3]   Antiamoebic and antigiardial activity of plant flavonoids [J].
Calzada, F ;
Meckes, M ;
Cedillo-Rivera, R .
PLANTA MEDICA, 1999, 65 (01) :78-80
[4]  
FARTHING MJG, 1994, GIARDIA: FROM MOLECULES TO DISEASE, P15
[5]  
HILL DR, 1993, INFECT DIS CLIN N AM, V7, P503
[6]  
Hill DR, 1995, PRINCIPLES PRACTICE, V2, P2487
[7]   METRONIDAZOLE AND DRUG-RESISTANCE [J].
JOHNSON, PJ .
PARASITOLOGY TODAY, 1993, 9 (05) :183-186
[9]  
Kramer M H, 1996, MMWR CDC Surveill Summ, V45, P1
[10]   CLINICAL PHARMACOKINETICS OF METRONIDAZOLE AND OTHER NITROIMIDAZOLE ANTIINFECTIVES [J].
LAU, AH ;
LAM, NP ;
PISCITELLI, SC ;
WILKES, L ;
DANZIGER, LH .
CLINICAL PHARMACOKINETICS, 1992, 23 (05) :328-364